|
 The move is part of efforts to bring pharmaceutical manufacturing to
the United States from abroad. Phlow Corp is a generic drug maker
based in Virginia which makes medicines overseas, mostly in India
and China, according https://nyti.ms/36dylna to the NYT.
Trump's trade adviser Peter Navarro, in an interview to NYT, called
this "a historic turning point in America's efforts to onshore its
pharmaceutical production and supply chains".
The number of coronavirus cases in the U.S exceeded 1.5 million on
Monday, as total deaths 90,000, according to a Reuters tally of
state and county figures.
The Biomedical Advanced Research and Development Authority, a part
of the U.S. Department of Health and Human Services, has awarded a
four-year contract to Phlow in which it will lead a team of private
sector entities that includes Civica Rx, Ampac Fine Chemicals, and
the Medicines for All Institute, according to the report.
[to top of second column] |
U.S. HHS Secretary Alex Azar called the initiative "a significant
step to rebuild our domestic ability to protect ourselves from
health threats," in a statement that the administration plans to
make public Tuesday morning, according to the NYT.
The NYT added that the contract may be extended for a total of $812
million over 10 years, making it one of the largest awards in the
authority's history.
The HHS, Phlow, Civica, Ampac and Medicines for All Institute were
not immediately available for a comment.
(Reporting by Rama Venkat in Bengaluru; Editing by Kim Coghill)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
